EVELYN ASANTE: Open Payments
NPI 1639165004 · CUMBERLAND, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 29 payments from 14 companies in 2025. Trend: 2023 $277 · 2024 $957 · 2025 $1,010
Food & beverage: $1,010
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $366 |
| Novo Nordisk Inc | 6 | $252 |
| ABBVIE INC. | 2 | $136 |
| Lundbeck LLC | 4 | $66 |
| Astellas Pharma US Inc | 1 | $31 |
| Dexcom, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Indivior Inc. | 1 | $18 |
Products named: AIRSUPRA, Ozempic, RINVOQ, Wegovy, REXULTI, BREZTRI, Veozah, Dexcom G6 Transmitter.
Industry payments across RI — which companies pay providers there.
